Avior Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
2,063
-187
-8% -$64K 0.02% 426
2026
Q1
$792K Buy
2,250
+364
+19% +$130K 0.02% 415
2025
Q4
$617K Buy
1,886
+666
+55% +$211K 0.02% 413
2025
Q3
$344K Sell
1,220
-3
-0.2% -$870 0.01% 554
2025
Q2
$341K Sell
1,223
-1,260
-51% -$357K 0.01% 536
2025
Q1
$774K Buy
2,483
+613
+33% +$181K 0.03% 313
2024
Q4
$487K Sell
1,870
-1,856
-50% -$551K 0.02% 450
2024
Q3
$1.2M Buy
3,726
+18
+0.5% +$5.89K 0.05% 252
2024
Q2
$1.16M Sell
3,708
-1,525
-29% -$448K 0.05% 238
2024
Q1
$1.49M Buy
5,233
+1,204
+30% +$352K 0.07% 208
2023
Q4
$1.16M Sell
4,029
-282
-7% -$76.8K 0.07% 184
2023
Q3
$1.16M Buy
4,311
+1,206
+39% +$301K 0.08% 172
2023
Q2
$690K Sell
3,105
-78
-2% -$18.1K 0.04% 271
2023
Q1
$770K Buy
3,183
+1,018
+47% +$250K 0.05% 240
2022
Q4
$569K Buy
2,165
+244
+13% +$65.4K 0.04% 273
2022
Q3
$432K Hold
1,921
0.04% 306
2022
Q2
$467K Sell
1,921
-35
-2% -$8.58K 0.05% 264
2022
Q1
$472K Buy
1,956
+35
+2% +$8.04K 0.04% 305
2021
Q4
$432K Hold
1,921
0.04% 347
2021
Q3
$408K Sell
1,921
-4,378
-70% -$1.01M 0.03% 344
2021
Q2
$1.53M Sell
6,299
-15
-0.2% -$3.69K 0.15% 127
2021
Q1
$1.57M Buy
6,314
+64
+1% +$15.3K 0.17% 123
2020
Q4
$1.44M Sell
6,250
-473
-7% -$109K 0.18% 119
2020
Q3
$1.71M Buy
6,723
+1,419
+27% +$352K 0.24% 96
2020
Q2
$1.25M Sell
5,304
-2,185
-29% -$499K 0.2% 121
2020
Q1
$1.52M Sell
7,489
-41
-0.5% -$8.96K 0.3% 88
2019
Q4
$1.81M Buy
7,530
+1,051
+16% +$232K 0.29% 89
2019
Q3
$1.25M Sell
6,479
-292
-4% -$56K 0.22% 105
2019
Q2
$1.25M Sell
6,771
-546
-7% -$97.8K 0.22% 103
2019
Q1
$1.39M Buy
7,317
+14
+0.2% +$2.67K 0.29% 87
2018
Q4
$1.42M Sell
7,303
-785
-10% -$153K 0.34% 74
2018
Q3
$1.68M Sell
8,088
-88
-1% -$17.3K 0.36% 74
2018
Q2
$1.51M Buy
8,176
+151
+2% +$26.7K 0.34% 77
2018
Q1
$1.37M Sell
8,025
-627
-7% -$115K 0.32% 84
2017
Q4
$1.5M Buy
8,652
+2,507
+41% +$444K 0.34% 81
2017
Q3
$1.15M Buy
6,145
+350
+6% +$62K 0.38% 89
2017
Q2
$998K Buy
5,795
+4,945
+582% +$804K 0.41% 80
2017
Q1
$139K Buy
850
+813
+2,197% +$135K 0.05% 161
2016
Q4
$5K Buy
+37
New +$5.57K ﹤0.01% 381
2016
Q2
Sell
-94
Closed -$14K 463
2016
Q1
$14K Buy
94
+24
+34% +$3.57K 0.01% 321
2015
Q4
$11K Buy
+70
New +$11K 0.01% 307

Other funds holding AMGN

Avior Wealth Management's AMGN Position: Q2 2026 in Review

Avior Wealth Management reduced its Amgen (AMGN) stake by 8.3% in Q2 2026, selling an estimated $64K and leaving 2,063 shares worth $747K. The position accounts for 0.02% of the portfolio, ranked #426.

Avior Wealth Management first reported a position in AMGN in Q4 2015 and has held it in 41 quarters since. The position peaked at $1.81M in Q4 2019. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Avior Wealth Management held 2,063 shares of Amgen worth $747K as of Q2 2026.
  • Avior Wealth Management sold 187 Amgen shares in Q2 2026, an estimated $64K.
  • Amgen made up 0.02% of Avior Wealth Management's portfolio in Q2 2026, its #426 holding.
  • Avior Wealth Management first reported a position in Amgen in Q4 2015 and has held it in 41 quarters since.
  • Avior Wealth Management's Amgen position peaked at $1.81M in Q4 2019.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.